Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 11, 2012, Pages 1517-1521

  Conesa Botella, Anali ^a,b   Goovaerts, O ^a,b   Massinga Loembe, M ^a   Worodria, W ^c,d   Mazakpwe, D ^c,d   Luzinda, K ^c,d   Mayanja Kizza, H ^c   Colebunders, R ^a,b   Kestens, L ^b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^d Infectious Diseases Network for Treatment and Research in Africa INTERACT   (Uganda)

Author keywords

25 hydroxyvitamin D; HAART; Immune reconstitution

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT; VITAMIN D;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SPUTUM SMEAR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS; UGANDA; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84867194600     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0146     Document Type: Article

References (35)

1. Holick M F. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
2. Skull S A, Ngeow J Y, Biggs B A, Street A, Ebeling P R. Vitamin D deficiency is common and unrecognized among recently arrived adult immigrants from the Horn of Africa. Intern Med J 2003; 33: 47-51. (Pubitemid 36241574)
3. Moreno-Reyes R, Carpentier Y A, Boelaert M, et al. Vitamin D deficiency and hyperparathyroidism in relation to ethnicity: a cross-sectional survey in healthy adults. Eur J Nutr 2008; 48: 31-37.
4. Bang U C, Shakar S A, Hitz M F, et al. Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study. Scand J Infect Dis 2010; 42: 306-310.
5. Paul T V, Asha H S, Thomas N, et al. Hypovitaminosis D and bone mineral density in HIV-infected Indian men with or without antiretroviral therapy. Endocr Pract 2010; 16: 547-553.
6. Rodriguez M, Daniels B, Gunawardene S, Robbins G K. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009; 25: 9-14.
7. Rutstein R, Downes A, Zemel B, Schall J, Stallings V. Vitamin D status in children and young adults with perinatally acquired HIV infection. Clin Nutr 2011; 30: 624-628.
8. Gibney K B, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008; 46: 443-446. (Pubitemid 351263529)
9. Nnoaham K E, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37: 113-119. (Pubitemid 351228619)
10. Koeffler H P, Reichel H, Bishop J E, Norman A W. Gammai nterferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun 1985; 127: 596-603. (Pubitemid 16217468)
11. Holick M F, Chen T C. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87 (4): S1080-S1086.
12. Chocano-Bedoya P, Ronnenberg A G. Vitamin D and tuberculosis. Nutr Rev 2009; 67: 289-293.
13. Wilkinson R J, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case-control study. Lancet 2000; 355: 618-621. (Pubitemid 30099469)
14. Wejse C, Olesen R, Rabna P, et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr 2007; 86: 1376-1383. (Pubitemid 350126241)
15. Ustianowski A, Shaffer R, Collin S, Wilkinson R J, Davidson R N. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect 2005; 50: 432-437. (Pubitemid 40692029)
16. Martineau A R, Honecker F U, Wilkinson R J, Griffiths C J. Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007; 103: 793-798. (Pubitemid 46401341)
17. Nansera D, Graziano F M, Friedman D J, et al. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberc Lung Dis 2011; 15: 1522-1527.
18. Martineau A R, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci USA 2011; 108: 19013-19017.
19. Muller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 251-261.
20. Meintjes G, Lawn S D, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008; 8: 516-523. (Pubitemid 352005824)
21. Conesa-Botella A, Loembe M M, Manabe Y C, et al. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. J Acquir Immune Defic Syndr 2011; 58: 463-468.
22. Worodria W, Massinga-Loembe M, Mazakpwe D, et al. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr 2011; 58: 32-37.
23. French M A. Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Curr HIV/AIDS Rep 2007; 4: 16-21. (Pubitemid 46555247)
24. Conesa-Botella A, Mathieu C, Colebunders R, et al. Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome? AIDS Res Ther 2009; 6: 4.
25. Worodria W, Massinga-Loembe M, Mayanja-Kizza H, et al. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clin Dev I mmunol 2011; 2011: 758350.
26. Zerwekh J E. Blood biomarkers of vitamin D status. Am J Clin Nutr 2008; 87(4): S1087-S1091.
27. Van Den Bout-Van Den Beukel C J, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008; 24: 1375-1382.
28. Martineau A R, Wilkinson K A, Newton S M, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007; 178: 7190-7198. (Pubitemid 46847445)
29. Martineau A R, Timms P M, Bothamley G H, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-250.
30. Schuster I. Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 2011; 1814: 186-199.
31. Conesa-Botella A, Florence E, Lynen L, et al. Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther 2010; 7: 40.
32. Welz T, Childs K, Ibrahim F, et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010; 24: 1923-1928.
33. Mueller N J, Fux C A, Ledergerber B, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010; 24: 1127-1134.
34. Brodie M J, Boobis A R, Hillyard C J, et al. Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther 1982; 32: 525-530. (Pubitemid 13096730)
35. Mehta S, Giovannucci E, Mugusi F M, et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE 2010; 5: e8770.